Want to see FTLF full AI Analyst Report?
FitLife Brands (FTLF) Q2 2026 Earnings Report
FTLF Q2 2026 EPS Results
- Actual EPS
- $0.20
- Consensus EPS
- $0.20
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- $0.18
FTLF Q2 2026 Revenue Results
- Actual Revenue
- $26.55M
- Expected Revenue
- $26.00M
- Beat/Miss
- Beat by +$547.00K
- YoY Revenue Growth
- +64.62%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- Before Open
- Conference Call
- Thursday, August 13, 2026
FitLife Brands's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
Mixed results: strong consolidated revenue growth (+65% YoY) and improving sequential trends (total revenue +4.8% Q/Q), driven largely by the Irwin acquisition and Amazon scale-up, alongside profitability gains (net income and adjusted EBITDA up). However, margin compression (37.0% GM vs 42.8% prior), significant year-over-year declines at Legacy FitLife (total -23% YoY) and Legacy contribution (-25.9%) are notable concerns. Company progress on Irwin supply chain, Amazon traction, SG&A reductions, and debt paydown are encouraging, but channel risks (GNC), product mix issues, and near-term margin pressure keep the picture balanced.
The company's guidance focused on operational improvements and financial discipline to drive better margins and profitability: they expect supply‑chain fixes (85% of Irwin formulas approved for three‑year dating, 12% of SKUs on‑hand with three‑year dating and 22% with POs outstanding) and lower out‑of‑stock losses (down >50% Q2 vs Q1) to improve gross margin (company GM 37.0% in Q2; Legacy 41.7%; Irwin 32.8%); product cadence targets at least four new product launches per quarter beginning in 2027; marketing was increased (+16.4% sequentially) to boost off‑Amazon awareness and Amazon performance (Irwin Amazon monthly revenue: ~$0.5M Dec ’25, ~$0.8M Mar ’26, ~<$1.0M June; July comparable; active Amazon subscribers ~94k vs ~90k in mid‑April); SG&A was ~$4.8M (down 3.8% q/q, ~ $0.8M annualized) with further reductions planned; and excess free cash flow will be used to pay down debt (term loan $36.1M after $1.5M amortization; revolver $2.0M after $2.2M paydown; ~$8.6M repaid since the acquisition, saving ~ $0.6M annually at a 6.5% weighted interest rate), all of which management expects to translate into improved margins and profitability in coming quarters.
- Strong Consolidated Revenue Growth (YoY)Total revenue of $26.5M, up 65% year-over-year, primarily driven by the Irwin acquisition.
- Wholesale Revenue SurgeWholesale revenue was $14.6M (55% of total), increasing 156% year-over-year.
- Online Revenue GrowthOnline revenue was $11.9M (45% of total), up 14% year-over-year and up 6.3% sequentially vs Q1 2026.
- Profitability and EBITDA ImprovementNet income of $2.0M (vs $1.7M prior-year) and Adjusted EBITDA of $3.7M, a 10% increase year-over-year; contribution (gross profit less advertising) increased 46% year-over-year.
- Sequential Operational MomentumTotal revenue grew 4.8% sequentially (Q2 vs Q1 2026); wholesale +3.7% and online +6.3%. Diluted EPS increased sequentially in each of the past three quarters.
- Irwin Amazon Scale-UpIrwin Amazon monthly revenue scaled from ~$0.5M (Dec 2025) to ~$0.8M (Mar 2026) and just under $1.0M (June 2026); July revenue remained comparable to June without Prime Day.
- Supply Chain Progress at IrwinApproved three-year formulas for ~85% of Irwin products; inventory on-hand with three-year dating for 12% of SKUs and POs outstanding for an additional 22%; lost revenue from out-of-stocks declined >50% in Q2 vs Q1.
- SG&A and Debt ReductionSG&A approximately $4.8M in Q2, down 3.8% sequentially (~$0.8M annualized savings). Made $1.5M amortization payment (term loan balance $36.1M) and reduced revolver by $2.2M to $2.0M; paid off ~$8.6M indebtedness since acquisition, saving ~ $0.6M in annual interest at current rates.
- MusclePharm ImprovementMusclePharm showing sequential recovery: Q2 margins several hundred basis points higher vs prior quarters; recent double-digit growth on Amazon and initial Kroger placements (~700 locations) with early upticks.
- Amazon Subscriber RecoveryAmazon subscriber counts bottomed just above 90,000 in mid-April and have increased to ~94,000 active subscribers, climbing almost every week since the bottom.
FTLF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | 0.24- | 0.09 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 0.200.20 | 0.18 | 11.11% (+0.02) | |
| May 14, 2026 | 2026 (Q1) | ―0.17 | 0.2 | -15.00% (-0.03) | |
| Apr 01, 2026 | 2025 (Q4) | 0.130.17 | 0.2 | -15.00% (-0.03) | |
| Nov 13, 2025 | 2025 (Q3) | 0.270.09 | 0.21 | -58.14% (-0.13) | |
| Aug 14, 2025 | 2025 (Q2) | 0.170.18 | 0.27 | -32.08% (-0.09) | |
| May 15, 2025 | 2025 (Q1) | 0.240.20 | 0.21 | -6.98% (-0.01) | |
| Mar 27, 2025 | 2024 (Q4) | 0.290.21 | 0.15 | 39.07% (+0.06) | |
| Nov 14, 2024 | 2024 (Q3) | 0.250.21 | 0.17 | 24.28% (+0.04) | |
| Aug 14, 2024 | 2024 (Q2) | ―0.27 | 0.2 | 31.84% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
